{
  "disease_name": "Liver cancer",
  "synonyms": [
    "Hepatic cancer",
    "Primary hepatic cancer",
    "Primary hepatic malignancy",
    "Hepatocellular carcinoma (HCC)",
    "Intrahepatic cholangiocarcinoma (CCA)",
    "Angiosarcoma of the liver",
    "Hemangiosarcoma of the liver",
    "Hepatoblastoma",
    "Liver metastasis",
    "Secondary liver cancer"
  ],
  "summary": "Liver cancer is cancer that starts in the liver. It can be primary, originating in the liver, or secondary, where cancer spreads from elsewhere in the body to the liver. Primary liver cancer is a significant global health concern, ranking as the sixth-most frequent cancer and fourth-leading cause of cancer death.",
  "causes": [
    "Hepatitis B virus (HBV) infection",
    "Hepatitis C virus (HCV) infection",
    "Alcohol-induced cirrhosis",
    "Aflatoxin exposure",
    "Nonalcoholic fatty liver disease (NAFLD)",
    "Nonalcoholic steatohepatitis (NASH)",
    "Liver flukes (Opisthorchis viverrini, Clonorchis sinensis)",
    "Sclerosing cholangitis",
    "Choledochal cysts",
    "Congenital hepatic fibrosis",
    "Caroli's disease",
    "Hereditary hemochromatosis",
    "Alpha-1-antitrypsin deficiency",
    "Glycogen storage diseases",
    "Porphyria cutanea tarda",
    "Wilson's disease",
    "Tyrosinemia",
    "Vinyl chloride exposure",
    "Arsenic exposure",
    "Thorotrast exposure",
    "Dioxins exposure",
    "Ionizing radiation"
  ],
  "risk_factors": [
    "Chronic liver disease",
    "Cirrhosis",
    "Obesity",
    "Metabolic syndrome",
    "Diabetes mellitus",
    "Smoking",
    "Primary sclerosing cholangitis",
    "Long-term oral contraceptive use",
    "Male sex",
    "Age (55-65 years old for diagnosis)",
    "Hepatitis B and C prevalence in geographic region",
    "Low birth weight (in children)",
    "Beckwith-Wiedemann syndrome (in children)",
    "Familial adenomatous polyposis (in children)",
    "Progressive familial intrahepatic cholestasis (in children)",
    "Trisomy 18 (in children)"
  ],
  "symptoms": [
    "Abdominal mass",
    "Abdominal pain",
    "Jaundice",
    "Weight loss",
    "Fatigue",
    "Fever",
    "Sweating",
    "Vomiting",
    "Anemia",
    "Back pain",
    "Itching",
    "Liver enlargement",
    "Night sweats"
  ],
  "diagnosis": [
    "Blood tests (e.g., alpha-fetoprotein (AFP), carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), cancer antigen 125 (CA125))",
    "Medical imaging (ultrasound, CT scan, MRI scan)",
    "Tissue biopsy",
    "Liver Imaging Reporting and Data System (LI-RADS)",
    "Endoscopic retrograde cholangiopancreatography (ERCP)",
    "Magnetic resonance cholangiopancreatography (MRCP)",
    "Liver function tests"
  ],
  "treatments": [
    "Surgery (partial resection, liver transplantation)",
    "Targeted therapy (e.g., sorafenib, atezolizumab, nivolumab, pembrolizumab, regorafenib)",
    "Radiation therapy",
    "Ablation therapy (percutaneous ablation, radiofrequency ablation, microwave ablation, cryotherapy)",
    "Embolization therapy (transarterial chemoembolization (TACE), transarterial radioembolization (TRACE))",
    "Chemotherapy (cisplatin, vincristine, cyclophosphamide, doxorubicin)",
    "Immunotherapy",
    "Photodynamic therapy",
    "Antiviral drugs (for hepatitis B and C)",
    "Supportive care"
  ],
  "related_genes": [
    "p53 tumor suppressor gene",
    "Glypican-3 (GPC3)"
  ],
  "subtypes": [
    "Hepatocellular carcinoma (HCC)",
    "Intrahepatic cholangiocarcinoma (CCA)",
    "Angiosarcoma of the liver",
    "Hemangiosarcoma of the liver",
    "Hepatoblastoma",
    "Embryonal sarcoma of liver",
    "Infantile choriocarcinoma of liver",
    "Biliary rhabdomyosarcoma",
    "Cholangiocellular cystadenocarcinoma"
  ]
}